石榴云医（PomDoctor，股票代码：POM）在纳斯达克上市首日表现优异，盘后继续大涨7.20%，延续了其强劲的上涨势头。
据悉，石榴云医是中国最大的慢病复诊平台，于2025年10月8日在纳斯达克成功上市。公司IPO发行价为4美元/股，市值约4.74亿美元。石榴云医成立于2010年，业务涵盖线下药房、医药电商、医药配送和互联网医疗等多个领域，核心业务聚焦于慢病复诊服务。
值得注意的是，石榴云医在上市首日盘中就录得12.50%的涨幅，显示出投资者对其发展前景的看好。此外，公司在上市前已完成九轮融资，投资方阵容强大，包括步长制药、分众传媒、京东集团、中科招商、红杉资本和高特佳投资等知名企业和机构。石榴云医的成功上市不仅标志着公司进入新的发展阶段，也反映出资本市场对中国数字健康医疗行业的青睐。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.